
NATURE . COM {
}
Title:
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors | British Journal of Cancer
Description:
Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) regulate colon cancer growth and metastasis. Previous studies utilizing antibodies against the VEGF receptor (DC101) or EGF receptor (C225) have demonstrated independently that these agents can inhibit tumour growth and induce apoptosis in colon cancer in in vivo and in vitro systems. We hypothesized that simultaneous blockade of the VEGF and EGF receptors would enhance the therapy of colon cancer in a mouse model of peritoneal carcinomatosis. Nude mice were given intraperitoneal injection of KM12L4 human colon cancer cells to generate peritoneal metastases. Mice were then randomized into one of four treatment groups: control, anti-VEGFR (DC101), anti-EGFR (C225), or DC101 and C225. Relative to the control group, treatment with DC101 or with DC101+C225 decreased tumour vascularity, growth, proliferation, formation of ascites and increased apoptosis of both tumour cells and endothelial cells. Although C225 therapy did not change any of the above parameters, C225 combined with DC101 led to a significant decrease in tumour vascularity and increases in tumour cell and endothelial cell apoptosis (vs the DC101 group). These findings suggest that DC101 inhibits angiogenesis, endothelial cell survival, and VEGF-mediated ascites formation in a murine model of colon cancer carcinomatosis. The addition of C225 to DC101 appears to lead to a further decrease in angiogenesis and ascites formation. Combination anti-VEGF and anti-EGFR therapy may represent a novel therapeutic strategy for the management of colon peritoneal carcinomatosis. Β© 2001 Cancer Research Campaign http://www.bjcancer.com
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Science
- Education
- Health & Fitness
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
ππ Tremendous Traffic: 10M - 20M visitors per month
Based on our best estimate, this website will receive around 17,414,592 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$219,500 per month
Our estimates place Nature.com's monthly online earnings from display ads at $146,325 to $402,393.
Keywords {π}
cancer, growth, article, pubmed, google, scholar, factor, cas, colon, endothelial, nature, receptor, vascular, res, human, content, carcinomatosis, liu, hicklin, ellis, apoptosis, cells, antibody, cookies, antibodies, epidermal, shaheen, bucana, vegf, metastasis, therapy, cell, angiogenesis, research, colorectal, privacy, open, tumour, model, peritoneal, mice, survival, monoclonal, carcinoma, clin, data, journal, access, egf, vivo,
Topics {βοΈ}
nature portfolio privacy policy nature advertising cancer research social media research 0/ reprints antiangiogenic therapy targeting anti-vegf antibody bevacizumab epidermal growth factor endothelial cell apoptosis org/statistics/cff2000/selectedcancers personal data anti-angiogenic therapeutic strategy combination anti-vegf endothelial cell survival tyrosine kinase receptor data protection dc101 inhibits angiogenesis permissions anti-vegfr2 antibody vegf-mediated ascites formation anti-egfr therapy colon peritoneal carcinomatosis human colon cancer human pancreatic carcinoma egf receptor highly metastatic cells hyperthermic intraperitoneal chemotherapy vivo survival factor colon cancer carcinomatosis privacy monoclonal antibodies targeting anti-egfr attenuates explore content similar content surgical oncology inhibit tumour growth generate peritoneal metastases journals search log c225 therapy european economic area beth israel hospital rodriguez-bigas ma zebrowski bk experimental neoplasia putnam jb jr malignant pleural effusions vascular endothelial
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
description:Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) regulate colon cancer growth and metastasis. Previous studies utilizing antibodies against the VEGF receptor (DC101) or EGF receptor (C225) have demonstrated independently that these agents can inhibit tumour growth and induce apoptosis in colon cancer in in vivo and in vitro systems. We hypothesized that simultaneous blockade of the VEGF and EGF receptors would enhance the therapy of colon cancer in a mouse model of peritoneal carcinomatosis. Nude mice were given intraperitoneal injection of KM12L4 human colon cancer cells to generate peritoneal metastases. Mice were then randomized into one of four treatment groups: control, anti-VEGFR (DC101), anti-EGFR (C225), or DC101 and C225. Relative to the control group, treatment with DC101 or with DC101+C225 decreased tumour vascularity, growth, proliferation, formation of ascites and increased apoptosis of both tumour cells and endothelial cells. Although C225 therapy did not change any of the above parameters, C225 combined with DC101 led to a significant decrease in tumour vascularity and increases in tumour cell and endothelial cell apoptosis (vs the DC101 group). These findings suggest that DC101 inhibits angiogenesis, endothelial cell survival, and VEGF-mediated ascites formation in a murine model of colon cancer carcinomatosis. The addition of C225 to DC101 appears to lead to a further decrease in angiogenesis and ascites formation. Combination anti-VEGF and anti-EGFR therapy may represent a novel therapeutic strategy for the management of colon peritoneal carcinomatosis. ΓΒ© 2001 Cancer Research Campaign
http://www.bjcancer.com
datePublished:2001-08-14T00:00:00Z
dateModified:2011-11-16T00:00:00Z
pageStart:584
pageEnd:589
sameAs:https://doi.org/10.1054/bjoc.2001.1936
keywords:
antiangiogenic therapy
VEGF
EGF
receptor
apoptosis
endothelial cell
DC101
C225
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:85
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R M Shaheen
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:S A Ahmad
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:W Liu
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:N Reinmuth
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Y D Jung
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:W W Tseng
affiliation:
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
type:Organization
type:Person
name:K E Drazan
affiliation:
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
type:Organization
type:Person
name:C D Bucana
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D J Hicklin
affiliation:
name:ImClone Systems Inc.
address:
name:ImClone Systems Inc., New York, USA
type:PostalAddress
type:Organization
type:Person
name:L M Ellis
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
description:Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) regulate colon cancer growth and metastasis. Previous studies utilizing antibodies against the VEGF receptor (DC101) or EGF receptor (C225) have demonstrated independently that these agents can inhibit tumour growth and induce apoptosis in colon cancer in in vivo and in vitro systems. We hypothesized that simultaneous blockade of the VEGF and EGF receptors would enhance the therapy of colon cancer in a mouse model of peritoneal carcinomatosis. Nude mice were given intraperitoneal injection of KM12L4 human colon cancer cells to generate peritoneal metastases. Mice were then randomized into one of four treatment groups: control, anti-VEGFR (DC101), anti-EGFR (C225), or DC101 and C225. Relative to the control group, treatment with DC101 or with DC101+C225 decreased tumour vascularity, growth, proliferation, formation of ascites and increased apoptosis of both tumour cells and endothelial cells. Although C225 therapy did not change any of the above parameters, C225 combined with DC101 led to a significant decrease in tumour vascularity and increases in tumour cell and endothelial cell apoptosis (vs the DC101 group). These findings suggest that DC101 inhibits angiogenesis, endothelial cell survival, and VEGF-mediated ascites formation in a murine model of colon cancer carcinomatosis. The addition of C225 to DC101 appears to lead to a further decrease in angiogenesis and ascites formation. Combination anti-VEGF and anti-EGFR therapy may represent a novel therapeutic strategy for the management of colon peritoneal carcinomatosis. ΓΒ© 2001 Cancer Research Campaign
http://www.bjcancer.com
datePublished:2001-08-14T00:00:00Z
dateModified:2011-11-16T00:00:00Z
pageStart:584
pageEnd:589
sameAs:https://doi.org/10.1054/bjoc.2001.1936
keywords:
antiangiogenic therapy
VEGF
EGF
receptor
apoptosis
endothelial cell
DC101
C225
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:85
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R M Shaheen
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:S A Ahmad
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:W Liu
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:N Reinmuth
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Y D Jung
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:W W Tseng
affiliation:
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
type:Organization
type:Person
name:K E Drazan
affiliation:
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
type:Organization
type:Person
name:C D Bucana
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D J Hicklin
affiliation:
name:ImClone Systems Inc.
address:
name:ImClone Systems Inc., New York, USA
type:PostalAddress
type:Organization
type:Person
name:L M Ellis
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:85
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:ImClone Systems Inc.
address:
name:ImClone Systems Inc., New York, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:R M Shaheen
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:S A Ahmad
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:W Liu
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:N Reinmuth
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Y D Jung
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:W W Tseng
affiliation:
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
type:Organization
name:K E Drazan
affiliation:
name:Stanford University
address:
name:Department of Surgery, Stanford University, Palo Alto, USA
type:PostalAddress
type:Organization
name:C D Bucana
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:D J Hicklin
affiliation:
name:ImClone Systems Inc.
address:
name:ImClone Systems Inc., New York, USA
type:PostalAddress
type:Organization
name:L M Ellis
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Surgery, Stanford University, Palo Alto, USA
name:Department of Surgery, Stanford University, Palo Alto, USA
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
name:ImClone Systems Inc., New York, USA
name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
External Links {π}(79)
- What's http://www.bjcancer.com's gross income?
- What's the financial intake of http://www.cancer.org/statistics/cff2000/selectedcancers.html%23col?
- Revenue of https://doi.org/10.1093%2Fcarcin%2F20.8.1445
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10426790 have?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Matrix%20metalloproteinase%20inhibition%20prevents%20colon%20cancer%20peritoneal%20carcinomatosis%20development%20and%20prolongs%20survival%20in%20rats&journal=Carcinogenesis&doi=10.1093%2Fcarcin%2F20.8.1445&volume=20&pages=1445-1451&publication_year=1999&author=Aparicio%2CT&author=Kermorgant%2CS&author=Dessirier%2CV&author=Lewin%2CMJ&author=Lehy%2CT
- How much does https://doi.org/10.1002%2F1097-0142%2820000801%2989%3A3%3C488%3A%3AAID-CNCR3%3E3.0.CO%3B2-X pull in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10931447 make?
- How much income does http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%20is%20an%20in%20vivo%20survival%20factor%20for%20tumor%20endothelium%20in%20a%20murine%20model%20of%20colorectal%20carcinoma%20liver%20metastases&journal=Cancer&doi=10.1002%2F1097-0142%2820000801%2989%3A3%3C488%3A%3AAID-CNCR3%3E3.0.CO%3B2-X&volume=89&pages=488-499&publication_year=2000&author=Bruns%2CCJ&author=Liu%2CW&author=Davis%2CDW&author=Shaheen%2CRM&author=McConkey%2CDJ&author=Wilson%2CMR&author=Bucana%2CCD&author=Hicklin%2CDJ&author=Ellis%2CLM have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10850439 generate monthly?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20the%20epidermal%20growth%20factor%20receptor%20signaling%20by%20a%20novel%20tyrosine%20kinase%20inhibitor%20leads%20to%20apoptosis%20of%20endothelial%20cells%20and%20therapy%20of%20human%20pancreatic%20carcinoma&journal=Cancer%20Res&volume=60&pages=2926-2935&publication_year=2000&author=Bruns%2CCJ&author=Solorzano%2CCC&author=Harbison%2CMT&author=Ozawa%2CS&author=Tsan%2CR&author=Fan%2CD&author=Abbruzzese%2CJ&author=Traxler%2CP&author=Buchdunger%2CE&author=Radinsky%2CR&author=Fidler%2CIJ?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10213228 have?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Antitumor%20activity%20of%20sequential%20treatment%20with%20topotecan%20and%20anti-epidermal%20growth%20factor%20receptor%20monoclonal%20antibody%20C225&journal=Clin%20Cancer%20Res&volume=5&pages=909-916&publication_year=1999&author=Ciardiello%2CF&author=Bianco%2CR&author=Damiano%2CV&author=De%20Lorenzo%2CS&author=Pepe%2CS&author=De%20Placido%2CS&author=Fan%2CZ&author=Mendelsohn%2CJ&author=Bianco%2CAR&author=Tortora%2CG?
- How much profit does https://doi.org/10.1016%2F0002-9610%2868%2990458-3 make?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=5723866
- How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20in%20carcinoma%20of%20the%20colon%20and%20rectum&journal=Am%20J%20Surg&doi=10.1016%2F0002-9610%2868%2990458-3&volume=116&pages=875-881&publication_year=1968&author=Copeland%2CEM&author=Miller%2CLD&author=Jones%2CRS gross monthly?
- How much does https://doi.org/10.1056%2FNEJM199512283332608 make?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7491141's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Seminars%20in%20Medicine%20of%20the%20Beth%20Israel%20Hospital%2C%20Boston.%20Clinical%20applications%20of%20research%20on%20angiogenesis%20%5Bsee%20comments%5D&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM199512283332608&volume=333&pages=1757-1763&publication_year=1995&author=Folkman%2CJ make?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9815926
- How much does http://scholar.google.com/scholar_lookup?&title=Biological%20efficacy%20of%20a%20chimeric%20antibody%20to%20the%20epidermal%20growth%20factor%20receptor%20in%20a%20human%20tumor%20xenograft%20model&journal=Clin%20Cancer%20Res&volume=1&pages=1311-1318&publication_year=1995&author=Goldstein%2CNI&author=Prewett%2CM&author=Zuklys%2CK&author=Rockwell%2CP&author=Mendelsohn%2CJ make?
- How much does http://scholar.google.com/scholar_lookup?&title=Vascular%20targeting%20of%20solid%20and%20ascites%20tumours%20with%20antibodies%20to%20vascular%20endothelial%20growth%20factor&journal=Eur%20J%20Cancer&volume=32A&pages=2467-2473&publication_year=1996&author=Ke%2CL&author=Qu%2CH&author=Nagy%2CJA&author=Eckelhoefer%2CIA&author=Masse%2CEM&author=Dvorak%2CAM&author=Dvorak%2CHF bring in each month?
- How much profit is https://doi.org/10.1054%2Fbjoc.2000.1201 making per month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10864208 bring in each month?
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363248
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Induction%20of%20apoptosis%20and%20activation%20of%20the%20caspase%20cascade%20by%20anti-EGF%20receptor%20monoclonal%20antibodies%20in%20DiFi%20human%20colon%20cancer%20cells%20do%20not%20involve%20the%20c-jun%20N-terminal%20kinase%20activity&journal=Br%20J%20Cancer&doi=10.1054%2Fbjoc.2000.1201&volume=82&pages=1991-1999&publication_year=2000&author=Liu%2CB&author=Fang%2CM&author=Schmidt%2CM&author=Lu%2CY&author=Mendelsohn%2CJ&author=Fan%2CZ
- How much does https://doi.org/10.3109%2F07357909909040593 gross monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10225003?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Prognostic%20factors%20affecting%20survival%20in%20patients%20with%20colorectal%20carcinomatosis&journal=Cancer%20Invest&doi=10.3109%2F07357909909040593&volume=17&pages=249-252&publication_year=1999&author=Marcus%2CEA&author=Weber%2CTK&author=Rodriguez-Bigas%2CMA&author=Driscoll%2CD&author=Meropol%2CNJ&author=Petrelli%2CNJ?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3349467
- Profit of http://scholar.google.com/scholar_lookup?&title=In%20vivo%20selection%20of%20highly%20metastatic%20cells%20from%20surgical%20specimens%20of%20different%20primary%20human%20colon%20carcinomas%20implanted%20into%20nude%20mice&journal=Cancer%20Res&volume=48&pages=1943-1948&publication_year=1988&author=Morikawa%2CK&author=Walker%2CSM&author=Jessup%2CJM&author=Fidler%2CIJ
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10037173 gross monthly?
- http://scholar.google.com/scholar_lookup?&title=Anti-epidermal%20growth%20factor%20receptor%20antibody%20C225%20inhibits%20angiogenesis%20in%20human%20transitional%20cell%20carcinoma%20growing%20orthotopically%20in%20nude%20mice&journal=Clin%20Cancer%20Res&volume=5&pages=257-265&publication_year=1999&author=Perrotte%2CP&author=Matsumoto%2CT&author=Inoue%2CK&author=Kuniyasu%2CH&author=Eve%2CBY&author=Hicklin%2CDJ&author=Radinsky%2CR&author=Dinney%2CCP's revenue stream
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10537299 each month?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Antivascular%20endothelial%20growth%20factor%20receptor%20%28fetal%20liver%20kinase%201%29%20monoclonal%20antibody%20inhibits%20tumor%20angiogenesis%20and%20growth%20of%20several%20mouse%20and%20human%20tumors&journal=Cancer%20Res&volume=59&pages=5209-5218&publication_year=1999&author=Prewett%2CM&author=Huber%2CJ&author=Li%2CY&author=Santiago%2CA&author=O%27Connor%2CW&author=King%2CK&author=Overholser%2CJ&author=Hooper%2CA&author=Pytowski%2CB&author=Witte%2CL&author=Bohlen%2CP&author=Hicklin%2CDJ
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9815883?
- How much does http://scholar.google.com/scholar_lookup?&title=Level%20and%20function%20of%20epidermal%20growth%20factor%20receptor%20predict%20the%20metastatic%20potential%20of%20human%20colon%20carcinoma%20cells&journal=Clin%20Cancer%20Res&volume=1&pages=19-31&publication_year=1995&author=Radinsky%2CR net monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2155059 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Purification%20and%20NH2-terminal%20amino%20acid%20sequence%20of%20guinea%20pig%20tumor-secreted%20vascular%20permeability%20factor&journal=Cancer%20Res&volume=50&pages=1774-1778&publication_year=1990&author=Senger%2CDR&author=Connolly%2CDT&author=Van%20de%20Water%2CL&author=Feder%2CJ&author=Dvorak%2CHF make?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10554007?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Antiangiogenic%20therapy%20targeting%20the%20tyrosine%20kinase%20receptor%20for%20vascular%20endothelial%20growth%20factor%20receptor%20inhibits%20the%20growth%20of%20colon%20cancer%20liver%20metastasis%20and%20induces%20tumor%20and%20endothelial%20cell%20apoptosis&journal=Cancer%20Res&volume=59&pages=5412-5416&publication_year=1999&author=Shaheen%2CRM&author=Davis%2CDW&author=Liu%2CW&author=Zebrowski%2CBK&author=Wilson%2CMR&author=Bucana%2CCD&author=McConkey%2CDJ&author=McMahon%2CG&author=Ellis%2CLM produce monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7664263?
- http://scholar.google.com/scholar_lookup?&title=Expression%20of%20vascular%20endothelial%20growth%20factor%20and%20its%20receptor%2C%20KDR%2C%20correlates%20with%20vascularity%2C%20metastasis%2C%20and%20proliferation%20of%20human%20colon%20cancer&journal=Cancer%20Res&volume=55&pages=3964-3968&publication_year=1995&author=Takahashi%2CY&author=Kitadai%2CY&author=Bucana%2CCD&author=Cleary%2CKR&author=Ellis%2CLM's financial summary
- What's the financial gain of https://doi.org/10.1023%2FA%3A1006094117427?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9770111 rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=Monoclonal%20antibodies%20targeting%20the%20VEGF%20receptor-2%20%28Flk1%2FKDR%29%20as%20an%20anti-angiogenic%20therapeutic%20strategy&journal=Cancer%20Metastasis%20Rev&doi=10.1023%2FA%3A1006094117427&volume=17&pages=155-161&publication_year=1998&author=Witte%2CL&author=Hicklin%2CDJ&author=Zhu%2CZ&author=Pytowski%2CB&author=Kotanides%2CH&author=Rockwell%2CP&author=Bohlen%2CP bring in each month?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10589746
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%20levels%20and%20induction%20of%20permeability%20in%20malignant%20pleural%20effusions&journal=Clin%20Cancer%20Res&volume=5&pages=3364-3368&publication_year=1999&author=Zebrowski%2CBK&author=Yano%2CS&author=Liu%2CW&author=Shaheen%2CRM&author=Hicklin%2CDJ&author=Putnam%2CJB&author=Ellis%2CLM produce monthly?
- How much profit does https://citation-needed.springer.com/v2/references/10.1054/bjoc.2001.1936?format=refman&flavour=references make?
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20M%20Shaheen?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20M%20Shaheen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20A%20Ahmad?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20A%20Ahmad%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=W%20Liu's revenue stream
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22W%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N%20Reinmuth generate?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N%20Reinmuth%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Y%20D%20Jung
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Y%20D%20Jung%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=W%20W%20Tseng generate?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22W%20W%20Tseng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=K%20E%20Drazan's gross income?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22K%20E%20Drazan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20D%20Bucana
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20D%20Bucana%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20J%20Hicklin's gross income?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20J%20Hicklin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L%20M%20Ellis making per month?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L%20M%20Ellis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- What is the monthly revenue of https://s100.copyright.com/AppDispatchServlet?title=Inhibited%20growth%20of%20colon%20cancer%20carcinomatosis%20by%20antibodies%20to%20vascular%20endothelial%20and%20epidermal%20growth%20factor%20receptors&author=R%20M%20Shaheen%20et%20al&contentID=10.1054%2Fbjoc.2001.1936©right=The%20Author%28s%29&publication=0007-0920&publicationDate=2001-08-14&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY-NC-SA?
- What are the total earnings of https://citation-needed.springer.com/v2/references/10.1054/bjoc.2001.1936?format=refman&flavour=citation?
- How much cash flow does https://doi.org/10.1186/s40164-020-00159-1 have monthly?
- What's the financial intake of https://doi.org/10.1186/s13073-016-0369-x?
- How much does https://doi.org/10.1186/s12885-016-2834-8 gross monthly?
- Get to know https://doi.org/10.1007/s00280-016-3111-x's earnings
- How much money does https://doi.org/10.1007/s10585-016-9779-9 make?
- How much does https://www.protocols.io/ gross monthly?
- Monthly income for https://www.natureindex.com/
- What are the total earnings of http://www.naturechina.com?
- How much does https://www.natureasia.com/ja-jp bring in each month?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {π¦}
- Crossref